Akoya Biosciences Inc (AKYA) — Cash Flow-to-Debt Ratio
Latest as of March 2025:
-0.06x
Akoya Biosciences Inc (AKYA) has a Cash Flow-to-Debt Ratio of -0.06x as of March 2025, meaning its operating cash flow of $-7.21 Million could theoretically repay 0% of its total liabilities ($118.54 Million) in one year. See AKYA financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.06x
Operating CF / Total Liabilities
Operating Cash Flow
$-7.21 Million
USD
Total Liabilities
$118.54 Million
USD
Data as of
Mar 2025
Most recent filing
Akoya Biosciences Inc Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for Akoya Biosciences Inc across 6 annual periods. For the full cash flow conversion analysis, see Akoya Biosciences Inc operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Akoya Biosciences Inc (2019–2024)
Year-by-year debt coverage analysis for Akoya Biosciences Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.38x | $-44.10 Million | $117.41 Million | ▲ +6.6% |
| 2023 | -0.40x | $-50.90 Million | $126.60 Million | ▲ +11.7% |
| 2022 | -0.46x | $-53.50 Million | $117.45 Million | ▲ +12.2% |
| 2021 | -0.52x | $-36.07 Million | $69.56 Million | ▼ -347.8% |
| 2020 | -0.12x | $-6.84 Million | $59.09 Million | ▼ -0.5% |
| 2019 | -0.12x | $-13.78 Million | $119.57 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.